$RAPP
Rapport Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$40.45
▼-3.58%-$1.50
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRapport Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RAPP down today? It is at $40.45 (-3.58%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RAPP spikes, and full due diligence on RAPP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RAPP 27 times in the last 30 days. Create a free account to track $RAPP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RAPP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RAPP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ceesay Abraham Officer | Sold (automatic/other) | -8K 0.02% of company | sold 1.8% | 459K | $374K at $45.55 | Sep 8, 26 |
Yeleswaram Krishnaswamy Officer | Sold (automatic/other) | -37K 0.08% of company | sold 16% | 196K | $1.9M at $50.31 | Aug 25, 26 |
Ceesay Abraham Officer | Sold (automatic/other) | -19K 0.04% of company | sold 3.9% | 467K | $938K at $49.57 | Aug 25, 26 |
Yeleswaram Krishnaswamy Officer | Sold (automatic/other) | -13K 0.03% of company | sold 5.3% | 233K | $658K at $50.00 | Aug 24, 26 |
Yeleswaram Krishnaswamy Officer | Sold (automatic/other) | -404 | sold 0.2% | 246K | $20K at $49.90 | Aug 19, 26 |
Ceesay Abraham Officer | Sold (automatic/other) | -29K 0.06% of company | sold 5.6% | 486K | $1.4M at $46.90 | Aug 11, 26 |
Ceesay Abraham Officer | Sold (automatic/other) | -23K 0.05% of company | sold 4.2% | 515K | $1.0M at $45.97 | Aug 10, 26 |
Ceesay Abraham Officer | Sold (automatic/other) | -2K | sold 0.4% | 538K | $93K at $42.11 | Jul 27, 26 |
Ceesay Abraham Officer | Sold (automatic/other) | -8K 0.02% of company | sold 1.5% | 540K | $326K at $39.72 | Jul 14, 26 |
Gault Cheryl Officer | Sold (automatic/other) | -10K 0.02% of company | sold 6.3% | 150K | $401K at $40.09 | Jun 30, 26 |
Ceesay Abraham Officer | Sold (automatic/other) | -8K 0.02% of company | sold 1.5% | 548K | $327K at $39.77 | Jun 29, 26 |
Third Rock Ventures V, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -19K 0.04% of company | sold 0.3% | 6.28M | $744K at $40.05 | May 26, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RAPP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RAPP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RAPP last traded at $40.45, down 3.58% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Rapport Therapeutics, Inc. Common Stock (RAPP) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RAPP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RAPP 27 times in the last 30 days.
RAPP (Rapport Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.94B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RAPP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RAPP discussion
Sign in to ask a question or join the discussion.